Development Office Funding Opportunities

Eligibility:

•This is a collaborative, team-based grant requiring a minimum of four senior lead investigators, with representation from the United States, United Kingdom, Canada, and Australia.

oOne investigator must be designated as the Principal Investigator (PI). The PI may be based in any country, provided the country representation requirement (US, UK, CAN, AUS) is met.

oThe PI and all lead investigators must:
Hold full-time faculty or equivalent appointments at an accredited university, medical school, public health school, or non-profit research institution
Must have a doctoral degree at the time of LOI submission
May not be in training positions

•Teams must include involvement of an AI specialist or experienced AI researcher to ensure robust methodology and innovation.
•It is strongly preferred that teams include at least one member who is a clinician, MD/DO/PA, etc., or has relevant clinical experience, to ensure clinical translatability.

•Each applicant may only submit one LOI.

About: The program supports international, data-intensive research collaborations that apply artificial intelligence (AI), including machine learning, to advance ovarian cancer research and improve patient outcomes. New this year, OCRA is partnering with Amazon Web Services (AWS) to offer additional compute support through this grant program in the form of cloud-based compute credits to enable data-intensive AI research. Investigators may request up to $200,000 (USD) per year/up to $600,000 (USD) total of in kind AWS compute support, provided in addition to the financial support from the Global Ovarian Cancer Research Consortium (GOCRC).

Eligibility:

•Be a “faculty” member of SAEM in good standing at application deadline and during the entire award period.

•Have an advanced/doctoral or terminal educational degree (e.g., MD, DO, PhD, DSc or equivalent).

•Hold a university appointment in or be actively involved (e.g., have an adjunct appointment) with a department or division of emergency medicine or pediatric emergency medicine at the start of award period.

•Be an early career researcher, defined as completing initial residency training within eight (8) years of the start of the award period for physician applicants; non-physician applicants must be within 8 years of terminal research degree (PhD or equivalent). 

Eligibility:

•Be a “faculty” member of SAEM in good standing at application deadline and during the entire award period.

•Have an advanced/doctoral or terminal educational degree (e.g., MD, DO, PhD, DSc or equivalent).

•Hold a university appointment in or be actively involved (e.g., have an adjunct appointment) with a department or division of emergency medicine or pediatric emergency medicine at the start of award period. Emergency medicine residents in their final year of residency may apply, subject to the same stipulation of holding a university appointment at the start of the award period.

•Not have received a similar grant for the same purpose as the SAEMF proposal (no overlapping funds)  

About: The Emerging Infectious Disease and Preparedness Grant provides up to $100,000 over a one-year period starting July 1 to support emergency care research related to emerging infectious disease, such as influenza, COVID-19, and other bacterial or viral infections. This award is not limited to specific conditions and may study an infectious disease at any point in its epidemiologic trajectory. This award seeks to support an ambitious program of acute care science in emerging infectious disease that may include:

•Diagnostics
•Patient and provider safety
•Intervention/therapeutics
•Disaster preparedness
•Other relevant topic areas

In addition to existing basic, translational, and clinical research methods, projects leveraging innovative methodological designs, such as implementation trials, computational methods and data science are encouraged. While the focus is on self-limited research projects that are impactful in the current or future practice of emergency medicine and can be completed in a one-year time frame, the funds apportioned for this award are provided with the hope for investigators to propose an ambitious program of research that can lead to a sustained program of externally supported funded research.

Eligibility:

•Be a “faculty” member of SAEM in good standing at application deadline and during the entire award period.

•Have an advanced/doctoral or terminal educational degree (e.g., MD, DO, PhD, DSc or equivalent).

•Hold a university appointment in or be actively involved (e.g., have an adjunct appointment) with a department or division of emergency medicine or pediatric emergency medicine at the start of award period.

•Not have previously received a SAEMF Large Project Grant.

•Not have received an NIH R01 award or equivalent.

About:  The SAEMF Research Large Project Grant awards $150,000 over a two-year period ($75,000 per year) to support an emergency medicine faculty member to conduct a large-scale research project to advance his/her career and subsequently obtain federal funding by developing pilot data.

•The goals of the Research Large Project Grant are to:

•Answer important scientific questions in emergency medicine.

•Foster the growth of the awardee.

•Help the awardee become an independently funded scientist in emergency medicine research.

Eligibility:

•Be a “faculty” member of SAEM in good standing at application deadline and during the entire award period.

•Have an advanced/doctoral or terminal educational degree (e.g., MD, DO, PhD, DSc or equivalent).

•Hold a university appointment in or be actively involved (e.g., have an adjunct appointment) with a department or division of emergency medicine or pediatric emergency medicine at the start of award period.

About:  The goals of the SAEMF Research Training Grant are to:

•Provide support to an emergency medicine academician awardee for two years of concentrated training and mentorship with an emphasis on learning research methodology. The award is intended to support the development of sound research skills rather than a specific research project.

•Enhance the likelihood of the selection of an academic research career by the awardee.

•Facilitate the support of research training in the awardee’s host institution for emergency medicine research scientists.

•Encourage the awardee’s academic development and involvement in emergency medicine research.

Eligibility:

•Be a member of SAEM in good standing at application deadline and during the entire award period.

•Have an advanced/doctoral or terminal educational degree (e.g., MD, DO, PhD, PharmD, DSc or equivalent).

•Hold a university appointment in or be actively involved (e.g., have an adjunct appointment) with a department or division of emergency medicine or pediatric emergency medicine at the start of the award period, or be an emergency medicine resident in good standing in an Accreditation Council on Graduate Medical Education (ACGME)-approved emergency medicine residency program at the start of the award period. The applicant may work as a clinician at an institution other than the host institution or the institution at which the project will be conducted.

•Not have previously received the SAEMF/ED Benchmarking Alliance Clinical Operations Research Grant and not have received an NIH R01 award or equivalent.

About: The SAEMF/ED Benchmarking Alliance Clinical Operations Research Grant awards $50,000 over a two year period ($25,000 per year) to support an emergency medicine faculty member or trainee to conduct a research project to promote research on ED clinical operations. Operations research projects will investigate the experience of patients during their ED stay. This most often relates to flow and how factors such as consult turnaround time, lab / imaging turnaround time and other processes effect the patient. Patient satisfaction and ED design are also relevant. Special consideration will be given to projects addressing hospital over-capacity and resultant boarding of inpatients in the ED. Individuals with an interest in an administrative leadership or a research career relating to ED operations and care delivery are strongly encouraged to apply.

Eligibility:

Applicant must be an ACR or ARP member at the time of submission and for the duration of the award
•ACR Members:
oApplicant must be an NIH K08, K23, K25, VA CDA, or equivalent 4- or 5-year award recipient. The applicant must be in years 2, 3 or 4 of their award at the time of application.
oHave earned a DO, MD, MD/PhD, or DO/PhD degree or be currently enrolled in an ACGME accredited clinical training program.
•ARP Members:
oApplicant must be an NIH K01, K08, K23, K25, VA CDA, or equivalent 4- or 5-year award recipient. The applicant must be in years 2, 3 or 4 of their award at the time of application.
oHave earned a PhD*, DSc, or equivalent doctoral degree.

About:
The NIH K Series and VA CDA awards provide limited resources to cover research costs, such as essential laboratory supplies or support staff (e.g., salary support for a research technician, research assistant/coordinator, or statistician), which are crucial to the successful transition of junior investigators to independent investigators. This award is designed to address the needs of these investigators and serve as a supplement to the NIH individual K series, VA CDA, or equivalent 4- or 5-year award mechanism.
Applicants should propose a new project or expansion of their career development award that demonstrates growth of the aims of the initial award and an independent direction for the investigator leading to the submission of an R award or equivalent.

Amount: Up to $56,000 over 2 years

Eligibility:

•enrolled in a post-baccalaureate PhD, MD, DO, DVM, PharmD, DDS, DrPH, or PhD in nursing, public health, or equivalent clinical health science doctoral student who seeks research training with a sponsor prior to embarking upon a research career.

•a full-time student working towards his/her degree.

About: To enhance the integrated research and clinical training of promising students who are matriculated in pre-doctoral or clinical health professional degree training programs and who intend careers as scientists, physician-scientists or other clinician-scientists, or related careers aimed at improving global cardiovascular, cerebrovascular and brain health.

Eligibility:

•At the time of award activation, the applicant must hold a post-baccalaureate PhD degree or equivalent, or a doctoral-level clinical degree such as MD, DO, DVM, PharMD, DDS, DPh, or PhD in nursing, public health or other clinical health science.

•At the time of award activation, the awardee may not be pursuing a doctoral degree.

•At the time of award activation, the applicant may have no more than five years of research training or experience since obtaining a post-baccalaureate doctoral-level degree

About: The goal of this fellowship is to enhance the training of postdoctoral applicants who are not yet independent.

Eligibility:

•Eligible applicants include PhD candidates (preliminary exams completed) and medical professional students (to support a one-year hiatus from professional training to pursue research), and post-doctoral fellows (within 3 years of PhD or clinical degree).

oMedical professional training programs and clinical degrees include the following training programs and degrees: DDS, DO, DVM, MD, VMD and equivalents.

•Fellow applicants must have a principal mentor who satisfies the institutional requirements of a PI as defined above under the Research Tier I and II Grants heading.

About: The Fellow-Initiated application will, in most cases, address a Tier II level question. In rare cases the research may approach Tier I level research in scope. Research interests include:

•Discrete studies or deliverables involving drug repurposing, models, etc.
•Research needs designed to make possible a significant and new research grant
•Research needs designed to improve a significant research grant resubmission
•Analysis of previously compiled data or research resources
•Pre-clinical extension to an alternate syndrome of a previously validated therapy

Amount: $100,000 over 1-2 years

• Opportunity for competitive renewal

Eligibility: —

Amount: $50,000 over 1-2 years

• Opportunity for competitive renewal

Eligibility: —

About: Research interests include:

• Discrete studies or deliverables involving drug repurposing, models, etc.

• Research needs designed to make possible a significant and new research grant

• Research needs designed to improve a significant research grant resubmission

• Analysis of previously compiled data or research resources

• Pre-clinical extension to an alternate syndrome of a previously validated therapy  

Eligibility:

•Anesthesiology faculty members of any rank (junior or senior faculty)
About: Research in Education Grants (REG) advance the careers and knowledge of anesthesiologists interested in improving the concepts, methods and techniques of education in anesthesiology.

Eligibility:

•Anesthesiology faculty members of any rank (junior or senior faculty)

Eligibility:

•Anesthesiology trainees after CA-1 year 

Eligibility:

•Applicants must be established as an independent investigator in the field of gastric biology.

oMD applicants are considered “established” if 7 or more years have elapsed following the completion of clinical training
oPhD applicants are considered “established” if 7 or more years have elapsed following the awarding of the PhD degree

•Applicants for this award must hold an MD, PhD and/or equivalent degree (e.g., MBBS, MBChB, DO).

•Applicants performing any type of research (basic, translational, clinical) relevant to gastric cancer are eligible to apply.

Eligibility: —

About:The mission of Weiss Asset Management Foundation is to reduce human suffering globally. With an Allocation Committee composed of development economists and practitioners, we support evidence-based, cost-effective programs and research that we believe will yield a high, risk-adjusted social return on investment.
Examples of prior grants include support for evidence-based nutrition programming for children suffering from severe acute malnutrition, policy-oriented research to reduce barriers to vaccination programs, and technical assistance for government water-purification efforts.
We welcome all proposals related to our goal of reducing human suffering globally. We expect most grants to fall into the following two categories:

Project-based Support: We support work for specific initiatives.

•Research with high potential for impact on policy or programs
•Technical assistance
•Operational innovations and experiments for unique programmatic opportunities; and
•Support for proven, cost-effective programs that face funding gaps
•Note: For research proposals, we prioritize rigorous causal identification, data science for targeting, and important monitoring or descriptive work that could lead to action. We deprioritize simple correlations or purely qualitative work.

•General Support: We also provide general support for highly cost-effective organizations or programs.

Eligibility:

•Primary investigators (not co-investigators) who have completed work on a FAER Mentored Research Training Grant within the past two years and are in the process of revising and resubmitting an application for new independent research funding (R01/21, VA Merit, AHRQ or equivalent). The application for new independent funding should have received a priority score or percentile but have fallen just outside of the funding threshold 

Amount:
• Stage 1 (Piloting): Up to $200,000 over 5 years

• Stage 2 (Testing & Positioning for Scale): Up to $500,000 over 5 years

• Stage 3 (Transitioning to Scale): Up to $1.5M over 5 years

Eligibility:

•We support innovations addressing challenges in low-income, lower-middle-income and upper-middle-income countries, in line with the World Bank’s income classification.

About: The DIV Fund supports innovators and researchers piloting, rigorously testing, and scaling ways to meaningfully and measurably improve the lives of people living in poverty. We are deliberately open to all kinds of innovations, operating across all sectors, with potential to impact the lives of millions of people when delivered at scale. We are open to innovations with any viable pathway to scale, be that through public systems, philanthropic support, private markets, or a combination of funding sources. Our tiered criteria outline distinct requirements for three different stages, based on innovations’ proposed pathways to scale.

•Stage 1 grants support real-world pilots of promising innovations. These grants can be used to conduct testing to understand user demand, feasibility, impact potential, and financial viability. By the end of Stage 1, we want to know whether the innovation works in practice, if people will use it, and if it shows enough promise to warrant deeper investment.

•Stage 2 grants are used to determine if an innovation is measurably impactful and has a viable path to scale. These grants often include rigorous impact evaluations, and may support market validation, testing new delivery models, or evaluating scale readiness through strategic expansions. By the end of Stage 2, we want to know if the innovation significantly improves people’s lives, is cost-effective, and has a viable scaling model.

•Stage 3 grants accelerate the scale-up of validated, cost-effective innovations. Grantees need to demonstrate strong evidence of impact and cost-effectiveness, or commercial viability, and leverage partnerships to drive widespread adoption. By the end of Stage 3, we want to know that the innovation can achieve sustained impact at scale.